Bio

Clinical Focus


  • HIV Dementia
  • Psychopharmacology
  • Encephalopathies, HIV
  • Pain Disorder
  • Neuropharmacology
  • Acquired Immunodeficiency Syndrome
  • Transgender
  • AIDS Seroconversion
  • AIDS Long Term Survivors
  • Insomnia Disorder
  • Amphetamine-Related Disorders
  • Hepatitis C
  • Psychiatry
  • HIV-Associated Neurocognitive Disorder

Academic Appointments


Administrative Appointments


  • Principal Investigator, Stanford-SCC Methamphetamine Task Force (2002 - Present)

Honors & Awards


  • Burgiss HIV/AIDS LIfetime Achievement Award, Santa Clara County Board of Supervisors (December 2010)

Professional Education


  • Internship:St Vincent's Hospital and Medical Center (1997) NY
  • Residency:Harvard Medical School (2000) MA
  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2004)
  • Residency, Harvard Medical School - Cambridge Hospital, Psychiatry (2000)
  • Medical Education:Harvard Medical School (1996) MA

Community and International Work


  • AIDS Education and Training Center

    Topic

    HIV/AIDS and Comorbidities

    Partnering Organization(s)

    Community Health Partnership

    Populations Served

    HIV/AIDS, Community Physicians

    Location

    California

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    Yes

  • Stanford - Santa Clara Methamphetamine Task Force, Santa Clara County

    Topic

    Director

    Partnering Organization(s)

    AIDS Legal Services, The Health Trust

    Populations Served

    Santa Clara County

    Location

    Bay Area

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    Yes

Research & Scholarship

Current Research and Scholarly Interests


Methamphetamine Abuse
HIV Neuropsychiatry

Teaching

2013-14 Courses


Publications

Journal Articles


  • HIV/AIDS: Measuring an Evolving Virus Journal of Human Behavior in the Social Environment, Humble M, Pilkinton M, McGlynn L 2011; 21 (4): 398:409
  • A pilot study investigating the effects of trauma, experiential avoidance, and disease management in HIV-positive MSM using methamphetamine. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) Chartier, M., Vinatieri, T., Delonga, K., McGlynn, L. M., Gore-Felton, C., Koopman, C. 2010; 9 (2): 78-81

    Abstract

    With high rates of trauma among HIV-positive men who have sex with men (MSM) who use methamphetamine, this preliminary pilot study examined the associations between experiential avoidance, trauma symptoms, and management of a chronic illness. Among a small sample of HIV-positive, methamphetamine-using MSM in a California Bay Area County, greater reported experiential avoidance was significantly related to greater reported trauma and symptoms of traumatic stress. Furthermore, greater reported experiential avoidance was significantly related to reduced self-efficacy of illness management and more frequent methamphetamine use. Although further research is needed, these data suggest that addressing issues of experiential avoidance and trauma could affect behavioral choices and treatment outcomes in this high-risk population.

    View details for DOI 10.1177/1545109709360065

    View details for PubMedID 20142604

  • Personal Values and Meaning in the Use of Methamphetamine Among HIV-Positive Men Who Have Sex With Men QUALITATIVE HEALTH RESEARCH Chartier, M., Araneta, A., Duca, L., McGlynn, L. M., Gore-Felton, C., Goldblum, P., Koopman, C. 2009; 19 (4): 504-518

    Abstract

    Our aim with this qualitative study was to understand the role of personal values, meaning, and impact of drug use among HIV-positive men who have sex with men (MSM) who struggle with methamphetamine use. Participants were 22 MSM recruited from an ethnically diverse county in the San Francisco Bay area of California. Grounded theory was used to analyze the data collected in individual interviews. Emergent constructs of context, meaning, and perceived impact were identified and are described in a theoretical narrative format. The importance of broadening our understanding of HIV and methamphetamine addiction and their interaction is highlighted. This study contributes to the understanding of the complexity of methamphetamine use within the specific population of MSM living with HIV/ AIDS, and suggests possible directions for addressing important maintaining factors like adaptive use and enhancing factors that could contribute to an individual's ability to make better choices based on meaning and personal values.

    View details for DOI 10.1177/1049732309333018

    View details for Web of Science ID 000264405400008

    View details for PubMedID 19299756

  • Psychopharmacology and the HIV Positive Patient American Society of Clinical Psychopharmacology Model Psychopharmacology Curriculum (ASCP) for Training Directors and Teachers of Psychopharmacology in Psychiatric Residency Programs McGlynn LM, Marcus PH 2009; 5
  • HIV-associated cognitive impairment: key issues for providers. Focus (San Francisco, Calif.) McGlynn, L., Chartier, M. 2008; 23 (3): 5-8

    View details for PubMedID 19062783

  • IMPACT OF PNEUMOCYSTIS-CARINII AND CYTOMEGALOVIRUS ON THE COURSE AND OUTCOME OF ATYPICAL PNEUMONIA IN ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE JOURNAL OF INFECTIOUS DISEASES Bozzette, S. A., ARCIA, J., BARTOK, A. E., McGlynn, L. M., McCutchan, J. A., Richman, D. D., Spector, S. A. 1992; 165 (1): 93-98

    Abstract

    Patients undergoing bronchoscopy for possible pneumocystis pneumonia were studied retrospectively to characterize the impact of common viral pathogens on the course of advanced human immunodeficiency virus (HIV) disease and atypical pneumonia. In 327 episodes, Pneumocystis carinii was found in 220 (67%), cytomegalovirus (CMV) in 145 (44%), and herpes simplex virus in 16 (5%). Early deterioration in oxygenation and use of intensive care was less common in CMV-positive patients. Neither CMV nor P. carinii was a predictor of mortality in multivariate analyses. CMV was not associated with an increased prevalence of later CMV disease. Isolation of CMV from the bronchoalveolar lavage fluid of these patients was not an indication for antiviral therapy. Pulmonary shedding of CMV may be associated with a decreased inflammatory response to P. carinii. The outcome of HIV-associated atypical pneumonia where no clear pulmonary pathogen is found on routine evaluation was no better than that of treated P. carinii pneumonia.

    View details for Web of Science ID A1992GW58200012

    View details for PubMedID 1309375

  • The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia. journal of protozoology Bozzette, S. A., ARCIA, J., BARTOK, A. E., McGlynn, L. M., McCutchan, J. A., Richman, D. D., Spragg, R., Spector, S. A. 1991; 38 (6): 183S-184S

    Abstract

    A large retrospective study was conducted to evaluate the impact of culturing cytomegalovirus from the respiratory secretions of AIDS patients with Pneumocystis carinii pneumonia. Pneumocystis carinii was found in 220 (67%) of 327 episodes and cytomegalovirus was found in 106 (48%) of the P. carinii-positive patients. Cytomegalovirus-positive and -negative patients were similar at baseline and had a similar number of hospital days, but had a lower incidence of early deterioration in oxygenation, fewer intensive-care days, were less frequently intubated, and had a higher 30-day survival. The better short-term outcome of cytomegalovirus positive patients observed in this study may relate to the immunosuppressive effects of cytomegalovirus.

    View details for PubMedID 1667929

Footer Links:

Stanford Medicine Resources: